GI
CLVS

GAMCO Investors’s Clovis Oncology, Inc. CLVS Stock Holding History

GAMCO Investors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-145,400
Closed -$173K – 925
2022
Q3 		$173K Sell
145,400
-12,950
-8% -$20.2K ﹤0.01% 840
2022
Q2 		$285K Sell
158,350
-14,700
-8% -$21.7K ﹤0.01% 780
2022
Q1 		$350K Buy
173,050
+5,000
+3% +$9.82K ﹤0.01% 778
2021
Q4 		$455K Sell
168,050
-28,250
-14% -$104K ﹤0.01% 748
2021
Q3 		$875K Sell
196,300
-9,000
-4% -$43.3K 0.01% 651
2021
Q2 		$1.19M Buy
205,300
+7,850
+4% +$46K 0.01% 621
2021
Q1 		$1.39M Sell
197,450
-123,000
-38% -$825K 0.01% 570
2020
Q4 		$1.54M Buy
320,450
+8,150
+3% +$41.2K 0.01% 527
2020
Q3 		$1.82M Sell
312,300
-7,600
-2% -$45.5K 0.02% 476
2020
Q2 		$2.16M Buy
319,900
+8,300
+3% +$62.8K 0.02% 444
2020
Q1 		$1.98M Buy
311,600
+3,970
+1% +$31.8K 0.02% 429
2019
Q4 		$3.21M Sell
307,630
-61,745
-17% -$449K 0.03% 417
2019
Q3 		$1.45M Buy
369,375
+169,825
+85% +$1.37M 0.01% 540
2019
Q2 		$2.97M Buy
199,550
+144,850
+265% +$2.62M 0.02% 443
2019
Q1 		$1.36M Buy
+54,700
New +$1.37M 0.01% 535

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

GAMCO Investors's CLVS Position: Q4 2022 in Review

GAMCO Investors sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 145,400 shares — an estimated $173K sold.

GAMCO Investors first reported a position in CLVS in Q1 2019 and held it in 15 quarters. The position peaked at $3.21M in Q4 2019. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • GAMCO Investors reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • GAMCO Investors sold 145,400 Clovis Oncology, Inc. shares in Q4 2022, an estimated $173K.
  • GAMCO Investors first reported a position in Clovis Oncology, Inc. in Q1 2019 and held it in 15 quarters.
  • GAMCO Investors's Clovis Oncology, Inc. position peaked at $3.21M in Q4 2019.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on GAMCO Investors's 13F filing for Q4 2022, filed 13 Feb 2023.